Meal-induced insulin sensitization and its parasympathetic regulation in humans

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 12, 2008, Pages 880-888

  Patarrão, Rita S ^a   Lautt, W Wayne ^b   Afonso, Ricardo A ^a   Ribeiro, Rogério T ^a   Guarino, Maria P ^a   Fernandes, Ana B ^a   Boavida, José M ^c,d   Macedo, M Paula ^a,c  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Portuguese Diabetes Association   (Portugal)

^d Francisco Gentil Portuguese Oncology Institute   (Portugal)

Author keywords

Atropine; Feeding; Hepatic insulin sensitizing substance; Insulin resistance; Liver; Meal induced insulin sensitivity; Rapid insulin sensitivity test

Indexed keywords

ATROPINE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CHOLINERGIC ACTIVITY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; LIVER; MALE; NORMAL HUMAN; PARASYMPATHETIC FUNCTION; PRIORITY JOURNAL; TEST MEAL;

ADULT; ATROPINE; EATING; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; MALE; PARASYMPATHETIC NERVOUS SYSTEM; PARASYMPATHOLYTICS;

EID: 57349087711     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-080     Document Type: Article

References (41)

1. Bokemark, L., Froden, A., Attvall, S., Wikstrand, J., and Fagerberg, B. 2000. The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand. J. Clin. Lab. Invest. 60(1): 27-36. PMID:10757451.
2. Brown, J.H., and Taylor, P. 1996. Muscarinic receptor agonists and antagonists, 9th ed. New York: McGraw-Hill.
3. Ceriello, A. 2003. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia, 46(Suppl 1): M9-M16. PMID:12652353.
4. Ceriello, A. 2005. Postprandial hyperglycemia and diabetes complications: Is it time to treat? Diabetes, 54(1): 1-7. doi:10.2337/diabetes.54.1.1. PMID:15616004.
5. DeFronzo, R.A., Tobin, J.D., and Andres, R. 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237(3): E214-E223. PMID:382871.
6. Ferrannini, E., and Mari, A. 1998. How to measure insulin sensitivity. J. Hypertens. 16(7): 895-906. doi:10.1097/00004872-199816070-00001. PMID:9794728.
7. Greenfield, M.S., Doberne, L., Kraemer, F., Tobey, T., and Reaven, G. 1981. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes, 30(5): 387-392. doi:10.2337/diabetes.30.5. 387. PMID:7014307.
8. Guarino, M.P., Afonso, R.A., Raimundo, N., Raposo, J.F., and Macedo, M.P. 2003. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action. Am. J. Physiol. Gastrointest. Liver Physiol. 284(4): G588-G594. PMID: 12466146.
9. Guarino, M.P., Correia, N.C., Lautt, W.W., and Macedo, M.P. 2004. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 287(3): G527-G532. doi:10.1152/ajpgi.00085.2004. PMID:15331351.
10. Kraegen, E.W., James, D.E., Bennett, S.P., and Chisholm, D.J. 1983. In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am. J. Physiol. 245(1): E1-E7. PMID:6346896.
11. Latour, M.G., and Chan, C.C. 2002. A rapid insulin sensitivity test (RIST) in the anesthetized mice. Diabetes, 51(Suppl 2): A422. [Abstract.]
12. Latour, M.G., and Lautt, W.W. 2002a. The hepatic vagus nerve in the control of insulin sensitivity in the rat. Auton. Neurosci. 95(1-2): 125-130. doi:10.1016/S1566-0702(01)00390-3. PMID: 11871777.
13. Latour, M.G., and Lautt, W.W. 2002b. Insulin sensitivity regulated by feeding in the conscious unrestrained rat. Can. J. Physiol. Pharmacol. 80(1): 8-12. doi:10.1139/y01-094. PMID:11911229.
14. Lautt, W.W. 1999. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can. J. Physiol. Pharmacol. 77(8): 553-562. doi:10.1139/cjpp-77-8-553. PMID:10543718.
15. Lautt, W.W. 2003. Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: methods to quantitate mechanisms of insulin resistance. Med. Res. Rev. 23(1): 1-14. doi:10.1002/med.10022. PMID: 12424750.
16. Lautt, W.W. 2004. A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis. J. Pharmacol. Sci. 95(1): 9-17. doi:10.1254/jphs.95.9. PMID:15153645.
17. Lautt, W.W. 2007. Postprandial insulin resistance as an early predictive cardiovascular risk factor. Ther. Clin. Risk Manag. 3(5): 761-770. PMID:18473001.
18. Lautt, W.W., Wang, X., Sadri, P., Legare, D.J., and Macedo, M.P. 1998. Rapid insulin sensitivity test (RIST). Can. J. Physiol. Pharmacol. 76(12): 1080-1086. doi:10.1139/cjpp-76-12-1080. PMID:10326829.
19. Lautt, W.W., Macedo, M.P., Sadri, P., Takayama, S., Duarte Ramos, F., and Legare, D.J. 2001. Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am. J. Physiol. Gastrointest. Liver Physiol. 281(1): G29-G36. PMID:11408252.
20. Lautt, W.W., Ming, Z., Macedo, M.P., and Legare, D.J. 2008. HISS-dependent insulin resistance (HDIR) in aged rats is associated with adiposity, progresses to syndrome X, and is attenuated by a unique antioxidant cocktail. Exp. Gerontol., In press. PMID:18538970.
21. Moore, M.C., Satake, S., Baranowski, B., Hsieh, P.S., Neal, D.W., and Cherrington, A.D. 2002. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 282(2): E286-E296. PMID:11788359.
22. Nauck, M.A., Liess, H., Siegel, E.G., Niedmann, P.D., and Creutzfeldt, W. 1992. Critical evaluation of the 'heated-hand-technique' for obtaining 'arterialized' venous blood: incomplete arterialization and alterations in glucagon responses. Clin. Physiol. 12(5): 537-552. doi:10.1111/j.1475- 097X.1992.tb00357.x. PMID:1395446.
23. Patarrǎo, R.S., Lautt, W.W., Guarino, M.P., Afonso, R.A., Ribeiro, R.T., Fernandes, A.B., et al. 2007. A new technique to assess insulin sensitivity in humans: the rapid insulin sensitivity test (RIST). Proc. West. Pharmacol. Soc. 50: 105-109. PMID: 18605244.
24. Radziuk, J. 2000. Insulin sensitivity and its measurement: structural commonalities among the methods. J. Clin. Endocrinol. Metab. 85(12): 4426-4433. doi:10.1210/jc.85.12.4426. PMID:11134088.
25. Reid, M.A., and Lautt, W.W. 2004. Pattern of insulin delivery affects hepatic insulin sensitizing substance (HISS) action and insulin resistance. Can. J. Physiol. Pharmacol. 82(12): 1068-1074. doi:10.1139/y04-111. PMID:15644948.
26. Reid, M.A., Latour, M.G., Legare, D.J., Rong, N., and Lautt, W.W. 2002. Comparison of the rapid insulin sensitivity test (RIST), the insulin tolerance test (ITT), and the hyperinsulinemic euglycemic clamp (HIEC) to measure insulin action in rats. Can. J. Physiol. Pharmacol. 80(8): 811-818. doi:10.1139/y02-102. PMID: 12269792.
27. Ribeiro, R.T., Lautt, W.W., Legare, D.J., and Macedo, M.P. 2005. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia, 48(5): 976-983. doi:10.1007/s00125-005-1714-6.
28. Ribeiro, R.T., Afonso, R.A., and Macedo, M.P. 2007. Hepatic parasympathetic role in insulin resistance on an animal model of hypertension. Metabolism, 56(2): 227-233. doi:10.1016/j.metabol.2006.09.018. PMID:17224337.
29. Sadri, P., and Lautt, W.W. 1999. Blockade of hepatic nitric oxide synthase causes insulin resistance. Am. J. Physiol. 277(1 Pt 1): G101-G108. PMID:10409156.
30. Sadri, P., and Lautt, W.W. 2000. Glucose disposal by insulin, but not IGF-1, is dependent on the hepatic parasympathetic nerves. Can. J. Physiol. Pharmacol. 78(10): 807-812. doi:10.1139/cjpp-78-10-807. PMID:11077981.
31. Sadri, P., Reid, M.A., Afonso, R.A., Schafer, J., Legare, D.J., Macedo, M.P., et al. 2006. Meal-induced insulin sensitization in conscious and anaesthetized rat models comparing liquid mixed meal with glucose and sucrose. Br. J. Nutr. 95(2): 288-295. doi:10.1079/BJN20051644. PMID:16469144.
32. Scheen, A.J., Paquot, N., Castillo, M.J., and Lefebvre, P.J. 1994. How to measure insulin action in vivo. Diabetes Metab. Rev. 10(2): 151-188. PMID:7956677.
33. Soop, M., Nygren, J., Brismar, K., Thorell, A., and Ljungqvist, O. 2000. The hyperinsulinaemic-euglycaemic glucose clamp: reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects. Clin. Sci. (Lond.), 98(4): 367-374. PMID: 10731469.
34. Starr, J.I., Mako, M.E., Juhn, D., and Rubenstein, A.H. 1978. Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay. J. Lab. Clin. Med. 91(4): 691-692.
35. Takayama, S., Legare, D.J., and Lautt, W.W. 2000. Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc. West. Pharmacol. Soc. 43: 33-34. PMID:11056951.
36. Ting, J.W., and Lautt, W.W. 2006. The effect of acute, chronic, and prenatal ethanol exposure on insulin sensitivity. Pharmacol. Ther. 111(2): 346-373. doi:10.1016/j.pharmthera.2005.10.004. PMID:16310255.
37. Van De Borne, P., Hausberg, M., Hoffman, R.P., Mark, A.L., and Anderson, E.A. 1999. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 276(1): R178-R183.
38. Xie, H., and Lautt, W.W. 1995. Induction of insulin resistance by cholinergic blockade with atropine in the cat. J. Auton. Pharmacol. 15(5): 361-369. doi:10.1111/j.1474-8673.1995.tb00402.x. PMID:8744976.
39. Xie, H., and Lautt, W.W. 1996a. Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am. J. Physiol. 271(3 Pt 1): E587-E592. PMID: 8843755.
40. Xie, H., and Lautt, W.W. 1996b. Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am. J. Physiol. 270(5 Pt 1): E858-E863. PMID:8967475.
41. Xie, H., Zhu, L., Zhang, Y.L., Legare, D.J., and Lautt, W.W. 1996. Insulin sensitivity tested with a modified euglycemic technique in cats and rats. J. Pharmacol. Toxicol. Methods, 35(2): 77-82. doi:10.1016/1056- 8719(96)00003-2. PMID:8729433.